Skip to content

World Hepatitis Alliance launches first major policy report on viral hepatitis

Hospital admissions remain high amongst those with HIV

IL28B gene variation predicts response to hepatitis C treatment: will it change treatment of co-infection?

Successful hepatitis C treatment reduces HIV disease progression and non-liver-related mortality

Hepatitis C virus can survive in syringes for up to 63 days

Kidney dysfunction more frequent, increases risk of death of patients with HIV and hepatitis C co-infection

Detectable viral load, hepatitis C and cirrhosis risk factors for thrombocytopenia for patients with HIV

First hint of a hepatitis C vaccine?

Blood rather than semen mode of HCV transmission in HIV-positive gay men